Simon JA - Search Results

1

TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial.

Kingsberg SA, Derogatis L, Simon JA, Constantine GD, Graham S, Bernick B, Gasper G, Mirkin S. Kingsberg SA, et al. Among authors: simon ja. J Sex Med. 2016 Dec;13(12):1930-1937. doi: 10.1016/j.jsxm.2016.09.002. Epub 2016 Sep 28. J Sex Med. 2016. PMID: 27692842 Free article. Clinical Trial.

2

Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.

Simon JA; ESTRASORB Study Group. Simon JA, et al. Menopause. 2006 Mar-Apr;13(2):222-31. doi: 10.1097/01.gme.0000174096.56652.4f. Menopause. 2006. PMID: 16645536 Clinical Trial.

3

Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.

Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC. Simon JA, et al. Obstet Gynecol. 2007 Mar;109(3):588-96. doi: 10.1097/01.AOG.0000254160.62588.41. Obstet Gynecol. 2007. PMID: 17329509 Clinical Trial.

4

The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Kingsberg SA, Simon JA, Goldstein I. Kingsberg SA, et al. Among authors: simon ja. J Sex Med. 2008 Sep 2;5 Suppl 4:182-93; quiz 193. doi: 10.1111/j.1743-6109.2008.00961.x. J Sex Med. 2008. PMID: 18783534 Review.

5

Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.

Simon J, Nachtigall L, Gut R, Lang E, Archer DF, Utian W. Simon J, et al. Obstet Gynecol. 2008 Nov;112(5):1053-60. doi: 10.1097/AOG.0b013e31818aa7c3. Obstet Gynecol. 2008. PMID: 18978105 Clinical Trial.

6

Vulvovaginal atrophy: current and future therapies (CME).

Ibe C, Simon JA. Ibe C, et al. Among authors: simon ja. J Sex Med. 2010 Mar;7(3):1042-50; quiz 1051. doi: 10.1111/j.1743-6109.2009.01692.x. J Sex Med. 2010. PMID: 20500443 Review.

7

One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus.

Simon JA, Lin VH, Radovich C, Bachmann GA; Ospemifene Study Group. Simon JA, et al. Menopause. 2013 Apr;20(4):418-27. doi: 10.1097/gme.0b013e31826d36ba. Menopause. 2013. PMID: 23096251 Clinical Trial.

8

Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners.

Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V. Simon JA, et al. Menopause. 2014 Feb;21(2):137-42. doi: 10.1097/GME.0b013e318295236f. Menopause. 2014. PMID: 23736862

9

The CLOSER (CLarifying Vaginal Atrophy's Impact On SEx and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners.

Nappi RE, Kingsberg S, Maamari R, Simon J. Nappi RE, et al. J Sex Med. 2013 Sep;10(9):2232-41. doi: 10.1111/jsm.12235. Epub 2013 Jun 27. J Sex Med. 2013. PMID: 23809691

10

Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.

Simon JA, Maamari RV. Simon JA, et al. Climacteric. 2013 Aug;16 Suppl 1:37-43. doi: 10.3109/13697137.2013.807606. Climacteric. 2013. PMID: 23848490 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

479 results

Search Page

Filters